4WN1

Crystal structure of PDE10A in complex with 1-methyl-5-(1-methyl-3-{[4-(quinolin-2-yl)phenoxy]methyl}-1H-pyrazol-4-yl)pyridin-2(1H)-one

Summary for 4WN1

Entry DOI	10.2210/pdb4wn1/pdb
Descriptor	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, ZINC ION, MAGNESIUM ION, ... (5 entities in total)
Functional Keywords	phosphodiesterase, complex, inhibitor, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological source	Homo sapiens (Human)
Cellular location	Cytoplasm: Q9Y233
Total number of polymer chains	2
Total formula weight	79814.77
Authors	Amano, Y.,Honbou, K. (deposition date: 2014-10-10, release date: 2014-12-31, Last modification date: 2023-12-27)
Primary citation	Hamaguchi, W.,Masuda, N.,Miyamoto, S.,Shiina, Y.,Kikuchi, S.,Mihara, T.,Moriguchi, H.,Fushiki, H.,Murakami, Y.,Amano, Y.,Honbou, K.,Hattori, K. Synthesis, SAR study, and biological evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors with reduced CYP3A4 inhibition. Bioorg.Med.Chem., 23:297-313, 2015 Cited by PubMed: 25515954 DOI: 10.1016/j.bmc.2014.11.039 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (3.13 Å)

Structure validation